BML Capital Management as of Dec. 31, 2024
Portfolio Holdings for BML Capital Management
BML Capital Management holds 25 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aclaris Therapeutics (ACRS) | 22.0 | $35M | 14M | 2.48 | |
| Ishares Tr 0-3 Mnth Treasry (SGOV) | 16.2 | $26M | 260k | 100.32 | |
| Atea Pharmaceuticals (AVIR) | 15.8 | $26M | 7.6M | 3.35 | |
| Adverum Biotechnologies Com New (ADVM) | 6.6 | $11M | 2.3M | 4.67 | |
| An2 Therapeutics (ANTX) | 4.9 | $7.9M | 5.7M | 1.38 | |
| Instil Bio Com New (TIL) | 4.7 | $7.6M | 400k | 19.09 | |
| Essa Pharma Com New (EPIX) | 4.7 | $7.6M | 4.2M | 1.79 | |
| Aadi Bioscience (WHWK) | 4.1 | $6.6M | 2.1M | 3.15 | |
| Oramed Pharmaceuticals Com New (ORMP) | 4.0 | $6.4M | 2.6M | 2.42 | |
| Ikena Oncology (IKNA) | 3.7 | $5.9M | 3.6M | 1.64 | |
| Pmv Pharmaceuticals (PMVP) | 3.3 | $5.2M | 3.5M | 1.51 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 2.9 | $4.7M | 4.1M | 1.14 | |
| Connect Biopharma Hldgs Ads (CNTB) | 1.8 | $2.9M | 2.1M | 1.38 | |
| Milestone Pharmaceuticals (MIST) | 1.7 | $2.7M | 1.1M | 2.36 | |
| Athira Pharma (ATHA) | 1.0 | $1.6M | 2.8M | 0.59 | |
| Astrotech Corp (ASTC) | 0.9 | $1.5M | 220k | 6.72 | |
| Lisata Therapeutics (LSTA) | 0.5 | $848k | 285k | 2.98 | |
| Palvella Therapeutics Inc Ne (PVLA) | 0.3 | $506k | 42k | 12.00 | |
| Vistagen Therapeutics Ord (VTGN) | 0.3 | $443k | 150k | 2.95 | |
| Kezar Life Sciences Com New (KZR) | 0.2 | $327k | 49k | 6.72 | |
| Lenz Therapeutics (LENZ) | 0.2 | $268k | 9.3k | 28.87 | |
| Nextcure (NXTC) | 0.1 | $211k | 274k | 0.77 | |
| Verrica Pharmaceuticals | 0.1 | $122k | 175k | 0.70 | |
| Allovir (ALVR) | 0.0 | $77k | 184k | 0.42 | |
| Hillevax | 0.0 | $43k | 21k | 2.07 |
